Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00921_DB06414_nanopub.RAXAdOqW8hUqy3LoEayKqdZGrBs0pK_uacxZd36DVvkZw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00921_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00921_DB06414 label "DDI between Buprenorphine and Etravirine - Buprenorphine, when used concomitantly with etravirine, may experience a decrease in serum concentration. It is recommended to monitor for a decrease in buprenorphine levels (ie. reduced analgesia, and signs of opioid withdrawal). [drugbank_resource:DB00921_DB06414]" assertion.
- drugbank_resource:DB00921_DB06414 identifier "drugbank_resource:DB00921_DB06414" assertion.
- drugbank_resource:DB00921_DB06414 title "DDI between Buprenorphine and Etravirine - Buprenorphine, when used concomitantly with etravirine, may experience a decrease in serum concentration. It is recommended to monitor for a decrease in buprenorphine levels (ie. reduced analgesia, and signs of opioid withdrawal)." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00921_DB06414 assertion.
- drugbank:DB00921 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00921_DB06414 assertion.